MN-ENTRUST
19.10.2020 13:02:08 CEST | Business Wire | Press release
Entrust , a leading provider of trusted identities, payments and data protection, today announced the Sigma® Instant Desktop Issuance solution, an innovative direct-to-card solution for instant physical and mobile ID issuance. Designed for both cloud and on-premise deployment, the Sigma solution sets the standard for simple, secure and smart instant ID solutions across enterprise, healthcare, government, higher education and financial institutions.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201019005238/en/
Today’s enterprises face a myriad of security challenges: From transitioning to digital operations during the pandemic, to managing the global rise in cyber-attacks, they must maintain a safe and secure flow of data − including the data stored on physical credentials. Within these organizations, Identity and Access Management professionals require a printing solution that is not only easy to integrate into their operations, but one that evolves to meet the growing needs of their company while assuring the highest level of data security. Sigma systems deliver a seamless user experience across the issuance process for desktop and mobile printing needs. It eliminates the frustrations of printer set-up with a modular design and an out-of-the-box implementation that takes less than 30 minutes for users to begin issuing identities.
Equipped with cloud-based APIs, Sigma systems bring issuance to the cloud without additional hardware — enabling instant printing for both physical IDs, badges and payment cards. Sigma systems are trusted IoT devices that help ensure organizations and their data are safe with an intelligent network and building connectivity for ultimate enterprise protection. With capabilities like tactile impressions, holographic and luster panel printing, Sigma printers make it highly difficult for counterfeiters to alter or recreate cards. Additionally, features like an inline magnetic stripe and smart card encoding secure your cards during the card printing process.
“With our Sigma platform, we’re proud to deliver a best-in-class desktop credential issuance solution that’s designed to work completely and securely within a cloud environment, allowing financial, enterprise, government, higher education and healthcare organizations to meet high-volume issuance demands without sacrificing security or ease of use. The Sigma system is ready to meet the issuance needs of today, and equally important, will evolve to meet tomorrow’s security and technology challenges with unlimited printing applications,” said Tony Ball, Senior Vice President and General Manager of Instant Issuance at Entrust. “Entrust has been a pioneer in direct-to-card identity issuance technology for decades, and our Sigma system takes it to a whole new level.”
Sigma systems offer the most advanced security architecture that keeps data protected at each step of the issuance process:
- Encrypted connections: The connection and data sent between software and the printer are secure and encrypted. Sigma printers do not store customer data after successful printing is complete.
- Secure boot: This feature prevents Sigma systems from booting up malware or other compromises are detected.
- Trusted platform module (TPM): Organizations can store and manage user certificates and keys in the printer, allowing the printer to become a trusted internet of things (IoT) endpoint.
As large segments of the workforce continue operating remotely, Sigma systems are poised to meet the demands of a hybrid workforce with its physical and digital issuance platform. The Sigma system’s “Printer Dashboard” is available on mobile devices, allowing organizations to manage the printer from anywhere, without being tied to a desktop. Sigma systems also enable companies to pivot and move to a contactless ID Issuance experience, from online photo submission to validating the photo, printing the card, and ultimately delivering the card to the employee. Furthermore, the on-premises instant ID solution features a mobile enrollment functionality for added flexibility to issue IDs at various locations within a facility. Sigma systems use intelligent instant ID technology to streamline printing and eliminate manual workflows — bringing simplicity, security and flexibility to the issuance process.
“Whether your requirements demand an integrated, secure on-premises solution or a system that can grow with a distributed workforce via a secure cloud-hosted Identity Management offering, the Entrust Sigma solutions can meet your needs,” said Joe Franco, Director of Sales at Capture Technologies, an Entrust channel partner. “They are browser based and mobile ready and able to be deployed without the need for a heavy client to be installed. The certificate based integrated security features should put to rest any concerns about using the cloud for identity issuance or your printing solution being vulnerable to network attack.”
For more information about Sigma visit: https://www.entrust.com/c/meet-sigma .
About Entrust
Entrust keeps the world moving safely by enabling trusted identities, payments and data protection. Today more than ever, people demand seamless, secure experiences, whether they’re crossing borders, making a purchase, accessing e-government services or logging into corporate networks. Entrust offers an unmatched breadth of digital security and credential issuance solutions at the very heart of all these interactions. With more than 2,500 colleagues, a network of global partners, and customers in over 150 countries, it’s no wonder the world’s most entrusted organizations trust us. To learn more, visit www.entrust.com .
View source version on businesswire.com: https://www.businesswire.com/news/home/20201019005238/en/
Link:
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
FPT Named an OpenAI Select Partner6.8.2026 02:00:00 CEST | Press release
Global IT corporation FPT today announced that it has been named an OpenAI Select Partner within the OpenAI Partner Network. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260805503787/en/ FPT Named an OpenAI Select Partner The OpenAI Partner Network is a global program for partners to build, sell, and deliver AI solutions with OpenAI. It brings together partners with deep industry expertise, delivery capabilities, and customer relationships while equipping them with resources, enablement, and support to help enterprises adopt OpenAI frontier models and products and turn them into measurable impact. As an OpenAI Select Partner, FPT will continue working with OpenAI to help organizations build, deploy, and scale AI solutions responsibly and effectively. This work will help organizations get more useful work from every token and stronger performance per dollar with GPT‑5.6, while using ChatGPT Work to turn ambitious goals into
U.S. FDA Approves Takeda’s ORZEYFUL™ (oveporexton), the First and Only Medicine to Treat the Underlying Cause of Narcolepsy Type 16.8.2026 00:10:00 CEST | Press release
Adults Taking ORZEYFUL Experienced Significant and Meaningful Improvements Across the Full Range of Symptoms of Narcolepsy Type 1 (NT1) in Clinical Trials Compared to Those on Placebo As a First-in-Class Orexin Treatment, ORZEYFUL has the Potential to Redefine NT1 Care Beyond Individual Symptoms Takeda is Advancing U.S. Launch Preparations and Expects to Make ORZEYFUL Available Following Completion of the Drug Enforcement Administration (DEA) Scheduling Process Takeda (TSE:4502/NYSE:TAK) announced that the U.S. Food and Drug Administration (FDA) approved ORZEYFUL™ (oveporexton), an oral orexin receptor 2 (OX2R) agonist, for the treatment of narcolepsy type 1 (NT1, narcolepsy with cataplexy) in adults.* The persistent 24-hour nature of NT1 is driven by orexin deficiency and can severely impact people’s lives. As a first-in-class orexin treatment, ORZEYFUL is the only medicine indicated in the U.S. to treat the disease holistically rather than individual symptoms. “The FDA approval of OR
Compass Pathways Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)5.8.2026 22:30:00 CEST | Press release
Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to unlocking urgently needed new treatment options in mental health care, announced today that Compass granted equity awards under the Compass Pathways plc 2026 Inducement Plan to fourteen newly hired non-executive employees. The equity awards were granted on August 3, 2026 and consisted of options to purchase an aggregate of 139,355 shares and restricted share units or, in the case of employees in the United Kingdom nominal cost options, covering an aggregate of 66,300 shares. The options have an exercise price per share equal to $11.25, the closing price of the Company’s American Depositary Shares on the Nasdaq Global Select Market on the grant date, and will vest over a four-year period with 25% vesting on the first anniversary of the date of the grant and the remaining 75% vesting in equal monthly installments over the three-year period thereafter, subject to each employee’s continued employment. The restricted
Clinilabs Announces Medical Leadership Appointments5.8.2026 16:05:00 CEST | Press release
Bob Dagher, M.D., Named Chief Medical Officer and Waqar Ahmed Siddiqui, M.D., Named Principal Investigator Clinilabs (“Clinilabs LLC”), a global, full-service contract research organization (CRO) specializing in central nervous system (CNS) drug and device development, today announced the appointments of Bob Dagher, M.D., as Chief Medical Officer and Waqar Ahmed Siddiqui, M.D., as Principal Investigator of the Company’s Eatontown, New Jersey Clinical Research Unit (CRU). Dr. Dagher will provide strategic and medical leadership across the organization, while Dr. Siddiqui will lead the execution of research projects at the Company’s CRU. Together, they will support the design, development, and execution of clinical programs for pharmaceutical, biotechnology, and medical device sponsors advancing innovative therapies for psychiatric, neurological, substance use, and rare CNS disorders. “Clinilabs has earned the trust of sponsors by combining deep scientific expertise, medical leadership,
Interactive Brokers Adds Brazilian Futures through Brazil’s B3 Exchange5.8.2026 16:00:00 CEST | Press release
Interactive Brokers (Nasdaq: IBKR), an automated global broker, today announced that eligible clients outside of Brazil can now trade Brazilian futures in addition to equities through the B3 exchange. Interactive Brokers was the first broker to provide international investors with streamlined, low-cost access to B3. Offering Brazilian futures and equities alongside products across more than 170 markets worldwide underscores IBKR’s commitment to broadening global market access and giving clients efficient, cost-effective ways to diversify through a single, unified platform. Access to B3 provides exposure to one of Latin America’s most active and liquid markets, providing long-term growth potential across multiple sectors and another way for investors to pursue emerging market opportunities. "Global investors deserve seamless, low-cost access to the world's most compelling markets, including emerging economies shaping tomorrow's financial landscape," said Milan Galik, Chief Executive Off
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
